Clinical Trial Update: Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial of epinastine nasal spray in seasonal allergic rhinitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Epinastine nasal spray (epinastine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED